Clinicopathological and microbiological characteristics of mycobacterial otitis media in a medical center, 2000 to 2009

Journal of Infection

Volumn 62, Issue 3, 2011, Pages 243-246

  Hsiao, Cheng Hsiang ^a   Liu, Chia Ming ^a   Hsueh, Po Ren ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; IMIPENEM; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RNA 16S; TOBRAMYCIN;

ACID FAST BACTERIUM; ADULT; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; DEBRIDEMENT; DIPLOPIA; EAR DISEASE; FEMALE; GENE SEQUENCE; GRADENIGO SYNDROME; HEARING IMPAIRMENT; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOSPITAL INFECTION; HUMAN; LETTER; LUNG TUBERCULOSIS; MALE; MASTOIDECTOMY; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM TUBERCULOSIS; NASOPHARYNX CARCINOMA; OTALGIA; OTITIS MEDIA; OTORRHEA; TYMPANOPLASTY;

EID: 79952186895     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.01.006     Document Type: Letter

References (10)

1. Karcher H., Epple H.J., Schneider T., Eckmanns T., John P., Schweickert B. Nosocomial transmission of tuberculous otitis media in an ear, nose and throat outpatient unit: a clinical and hygienical investigation. J Infect 2010, 61:96-99.
2. TerKonda R.P., Levine S.C., Duvall A.J., Giebink G.S. Atypical mycobacterial otomastoiditis. Laryngoscope 1995, 105:1275-1278.
3. Cho Y.S., Lee H.S., Kim S.W., Chung K.H., Lee D.K., Koh W.J., et al. Tuberculous otitis media: a clinical and radiologic analysis of 52 patients. Laryngoscope 2006, 116:921-927.
4. Kahane J., Crane B.T. Tuberculous otitis media. Otol Neurotol 2009, 30:865-866.
5. van Ingen J., Looijmans F., Mirck P., Dekhuijzen R., Boeree M., van Soolingen D. Otomastoiditis caused by Mycobacterium abscessus, the Netherlands. Emerg Infect Dis 2010, 16:166-168.
6. Lai C.C., Lee L.N., Ding L.W., Yu C.J., Hsueh P.R., Yang P.C. Emergence of disseminated infections due to nontuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan. J Infect 2006, 53:77-84.
7. Hsiao CT, Tsai TF, Hsueh PR. Clinicopathological characteristics of skin and soft-tissue infection caused by nontuberculous mycobacteria in Taiwan. Int J Tuberc Lung Dis, in press.
8. Griffith D.E. Therapy of nontuberculous mycobacterial disease. Curr Opin Infect Dis 2007, 20:198-203.
9. Yang S.C., Hsueh P.R., Lai H.C., Teng L.J., Huang L.M., Chen J.M. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother 2003, 47:1958-1962.
10. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America.